×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
How a New Collaboration Between a Biopharmaceutical Company and a CRO Is Improving the Quality, Speed, and Efficiency of Drug Development
Session Chair(s)
Jami Norris, MS
Vice President, Clinical Development Strategic Partnerships
Quintiles, United States
This forum will explore how a novel collaboration between a biopharmaceutical company and service provider is optimizing productivity in the design and execution of studies with a focus on improving quality, speed, and efficiency.
Learning Objective : Describe how the companies are working together to determine the best development approaches for drug candidates within the biopharmaceutical company's portfolio; Share early successes, including how the quality, speed and productivity of drug development has improved; Discuss goals and implications of the partnership for patients and the biopharmaceutical industry.
Speaker(s)
Getting to Yes: Putting a Strategic Collaboration Between a Biopharmaceutical Company and a CRO into Action
Kathrin Schoenborn-Sobolewski
Merck KGAA, Germany
Global Head Clinical Trial Mgmt.
Have an account?